ISRCTN41194621已完成不适用
Randomised controlled trial of bezafibrate in patients with lower extremity arterial disease (LEAD)
Medical Research Council (MRC) (UK)0 个研究点目标入组 1,568 人开始时间: 2000年4月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,568
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Males with LEAD (no upper or lower age limit)
排除标准
- •1. Already on lipid-modifying agent
- •2. Renal or hepatic disease (including raised creatinine concentration)
- •3. Unstable angina; malignant disease
- •4. Serious intercurrent illness
研究者
相似试验
已完成
不适用
Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorderlong-chain fatty acid beta-oxydation disorderJPRN-UMIN000005257Department of Pediatrics, Kobe University Graduate School of Medicine,2
招募中
3 期
Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid TherapyCholestasisPrimary Sclerosing CholangitisNCT04309773Assistance Publique - Hôpitaux de Paris104
招募中
2 期
Randomized controlled trial of pemafibrate and fenofibrate for NAFLD with hypertriglyceridemiaJPRN-jRCTs031200280Iwaki Michihiro360
Unknown
3 期
Bezafibrate Trial in CPT2 DeficiencyCarnitine Palmitoyl Transferase 2 DeficiencyNCT00336167Assistance Publique - Hôpitaux de Paris12
已完成
2 期
Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBCPrimary Biliary CholangitisNCT05239468Intercept Pharmaceuticals72